These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32422022)

  • 21. Insulin-like modulation of Akt/FoxO signaling by copper ions is independent of insulin receptor.
    Hamann I; Petroll K; Grimm L; Hartwig A; Klotz LO
    Arch Biochem Biophys; 2014 Sep; 558():42-50. PubMed ID: 24933099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term high glucose exposure impairs insulin signaling in endothelial cells.
    De Nigris V; Pujadas G; La Sala L; Testa R; Genovese S; Ceriello A
    Cardiovasc Diabetol; 2015 Aug; 14():114. PubMed ID: 26297582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
    Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA
    Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
    Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
    Lassarre C; Ricort JM
    Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
    Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
    J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells.
    Failly M; Korur S; Egler V; Boulay JL; Lino MM; Imber R; Merlo A
    Mol Cancer Ther; 2007 Feb; 6(2):773-81. PubMed ID: 17308073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.
    Joy A; Kapoor M; Georges J; Butler L; Chang Y; Li C; Crouch A; Smirnov I; Nakada M; Hepler J; Marty M; Feuerstein BG
    J Neurooncol; 2016 Oct; 130(1):43-52. PubMed ID: 27422127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the insulin-like growth factor 1 receptor by CHM-1 blocks proliferation of glioblastoma multiforme cells.
    Lin YC; Hou SC; Hung CM; Lin JN; Chen WC; Ho CT; Kuo SC; Way TD
    Chem Biol Interact; 2015 Apr; 231():119-26. PubMed ID: 25643584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
    Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
    Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human insulin receptor juxtamembrane domain independent insulin signaling.
    Sattar AA; Berhanu C; Gebreselassie S; Berhanu P
    Cell Biol Int; 2007 Aug; 31(8):815-24. PubMed ID: 17344070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
    Gingras S; Côté S; Simard J
    Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin signaling through insulin receptor substrate 1 and 2 in normal liver development.
    Khamzina L; Gruppuso PA; Wands JR
    Gastroenterology; 2003 Aug; 125(2):572-85. PubMed ID: 12891559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular Glutamate-Induced mTORC1 Activation via the IR/IRS/PI3K/Akt Pathway Enhances the Expansion of Porcine Intestinal Stem Cells.
    Zhu M; Qin YC; Gao CQ; Yan HC; Li XG; Wang XQ
    J Agric Food Chem; 2019 Aug; 67(34):9510-9521. PubMed ID: 31382738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3K-AKT pathway negatively controls EGFR-dependent DNA-binding activity of Stat3 in glioblastoma multiforme cells.
    Ghosh MK; Sharma P; Harbor PC; Rahaman SO; Haque SJ
    Oncogene; 2005 Nov; 24(49):7290-300. PubMed ID: 16007122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor I receptor activity in human medulloblastomas.
    Del Valle L; Enam S; Lassak A; Wang JY; Croul S; Khalili K; Reiss K
    Clin Cancer Res; 2002 Jun; 8(6):1822-30. PubMed ID: 12060623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice.
    Carvalho-Filho MA; Ueno M; Carvalheira JB; Velloso LA; Saad MJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E476-82. PubMed ID: 16638822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
    Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
    J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.